Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.

ABSTRACT:

Introduction

Financial toxicity (FT) is a well-recognised problem in oncology. US-based studies have shown that: (a) cancer patients have a 2.7 times risk of bankruptcy; (b) patients who declare bankruptcy have a 79% greater hazard of death; (c) financial burden significantly impairs quality of life (QoL) and (d) reduces compliance and adherence to treatment prescriptions. The aim of the project is to develop and validate a patient-reported-outcome (PRO) measure to assess FT of cancer patients in Italy, where, despite the universal health coverage provided by the National Health Service, FT is an emerging issue.

Methods and analysis

Our hypothesis is that a specific FT measure, which considers the relevant sociocultural context and healthcare system, would allow us to unders

SUBMITTER: Riva S 

PROVIDER: S-EPMC6738930 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature